New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...

MedVi is a nationwide telehealth platform providing affordable, physician-supervised GLP-1 weight loss programs. Partnering with OpenLoop Health and FDA-regulated pharmacies, MedVi ensures high ...

In new guidance to medics, the European Association for the Study of Obesity praised the drugs' effectiveness and significant ...

Saxenda (liraglutide) and Wegovy (semaglutide) are prescription drugs used for weight loss and weight management. Both drugs come as a liquid solution injected under your skin. Saxenda is available in ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best growth stocks under $50 to buy now. On September 5, J.P. Morgan analyst Chris Schott maintained a Buy rating on Teva ...

Prescription drugs for obesity are gaining attention as lifestyle changes alone often fall short. Teva Pharmaceuticals (Teva) has launched the first generic glucagon-like peptide-1 (GLP-1) drug for ...

Teva Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration for the first generic GLP-1 medication for weight loss, the Parsippany-based company announced Aug. 28. The ...

Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) has announced US Food and Drug Administration (FDA) approval and launch of a generic version of Saxenda (liraglutide injection). Marketed ...

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist that must be used in combination with a reduced-calorie diet and increased physical activity. The medication is not ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...